BIOM on OTC

BIOMOLECULAR LIFE HOLDINGS, INC.

BIOMOLECULAR LIFE HOLDINGS, INC. is an American pharmaceutical preparations company, incorporated in Delaware.¹ It is headquartered in Miami, Florida.¹

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

TickerBIOM on OTC¹
IndustryPharmaceutical Preparations¹
HeadquartersMiami, Florida¹
Incorporated inDE²
Business address888 Brickell Key Dr,, # 306,, Miami, Fl 33131²
Filer categorySmaller reporting company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Fiscal year	2014
Revenue	$0³
Research and development	$865.7K³
Operating income	-$4.1M³
Interest	$2.8M³
Income tax	$0³
Net income	-$6.2M³

Fiscal year	2014
Current assets	$246.3K³
Total assets	$1.3M³
Current liabilities	$5.8M³
Shareholders’ equity	-$4.5M³
Shares outstanding	46.2M shares³

Fiscal year	2014
Capital spending	$0³

Compare BIOMOLECULAR LIFE HOLDINGS, INC. with another company

What it owns

What BIOMOLECULAR LIFE HOLDINGS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, net	$0³ Dec 31, 2014	$0³ Dec 31, 2013

Intangibles and goodwill

Item	Latest	A year before	Change
Finite-lived intangibles, net	$1.1M³ Dec 31, 2014	$1.1M³ Dec 31, 2013	0%

Leadership

Who has led BIOMOLECULAR LIFE HOLDINGS, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

Haig Keledjian2006–2007

President

Haig Keledjian2006–2007

2010201520202025

Chief executive officerHaig Keledjian Apr 7, 2006 to Nov 1, 2007⁴
PresidentHaig Keledjian Apr 7, 2006 to Jun 29, 2007⁴

Board members and other officers (5)

Exec. VP Fin; Bus & Corp DevMichael Capizzano Sep 25, 2007 to Sep 25, 2007⁵
Sr. VP Comm. & Corp. Dev.Monica Denise Ord Sep 12, 2006 to Sep 12, 2006⁶
Board memberElizabeth Hoffman Mar 13, 2006 to Mar 13, 2006⁷
Board memberHaig Keledjian Apr 7, 2006 to Nov 1, 2007⁴
Board memberHampar Karageozian Dec 19, 2006 to Jun 29, 2007⁸

Former names

SB Technology Holdings, Inc.May 4, 2026 to May 4, 2026²
VG Life Sciences Inc.Nov 13, 2014 to Mar 6, 2026²
VG Life Sciences, Inc.Jun 20, 2014 to Oct 14, 2014²
VIRAL GENETICS INC /DE/Apr 1, 2002 to Mar 25, 2009²
5 STARLIVING ONLINE INCJul 29, 1999 to Oct 18, 2001²

Timeline

Apr 7, 2006New chief executive Haig Keledjian becomes CEO⁴

Filings

5 filings to the SEC since October 2021: 5 other. The latest 5:

Oct 14, 202610-12G/A EDGAR
Sep 29, 202610-12G/A EDGAR
Aug 26, 202610-12G EDGAR
May 4, 2026RW EDGAR
Mar 6, 202610-12G EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How BIOMOLECULAR LIFE HOLDINGS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARBIOMOLECULAR LIFE HOLDINGS, INC.¹
CIK0001091326
Employer ID (EIN)33-0814123¹
Filer statusSmaller reporting company¹
Incorporated inDelaware¹
Fiscal year endsDecember 31¹
Industry code (SIC)2834 Pharmaceutical Preparations¹
SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
Business address888 Brickell Key Dr,, # 306,, Miami, FL 33131¹
Phone805-879-9000¹
Shares outstanding107,883,156 as of Nov 17, 2015⁹
Public float$1.3M as of Dec 31, 2014³
On EDGAR sinceJul 29, 1999¹
Filings210 in all: 8-K (37), 10QSB (20), NT 10-Q (20), 4 (17), CORRESP (12), 10-Q (10), NT 10-K (9), 424B3 (8)¹
All 40 form types
UPLOAD (8), 3 (7), 10KSB (6), 10KSB/A (5), 10-12G/A (4), 8-K/A (4), 10-12G (3), 10-K (3), REGDEX (3), REGDEX/A (3), 15-12G (2), 5 (2), DEF 14C (2), EFFECT (2), PRE 14C (2), RW (2), S-1 (2), S-1/A (2), SC 13D (2), 10QSB/A (1), 10SB12G (1), 3/A (1), 5/A (1), DEFS14A (1), NTN 10K (1), PREM14A (1), PRER14A (1), PRES14A (1), S-8 (1), SB-2 (1), SB-2/A (1), SC 14F1 (1)
Latest filingsAnnual report (10-K) Apr 15, 2015
Quarterly report (10-Q) Nov 19, 2015
Latest 8-K (8-K) Mar 30, 2016

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBIOMOLECULAR LIFE HOLDINGS, INC. filings on SEC EDGAR
2
SEC EDGARBIOMOLECULAR LIFE HOLDINGS, INC. filings on SEC EDGAR
3
SEC EDGARBIOMOLECULAR LIFE HOLDINGS, INC. 10-K for fiscal 2014
4
SEC EDGARHaig Keledjian, Chief executive officer
5
SEC EDGARMichael Capizzano, Exec. VP Fin; Bus & Corp Dev
6
SEC EDGARMonica Denise Ord, Sr. VP Comm. & Corp. Dev.
7
SEC EDGARElizabeth Hoffman, Board member
8
SEC EDGARHampar Karageozian, Board member
9
SEC EDGARBIOMOLECULAR LIFE HOLDINGS, INC. 10-Q filed Nov 19, 2015: shares outstanding